1. |
GULATI A, JABBOUR A, ISMAIL T F, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J]. JAMA, 2013, 309(9):896-908.
|
2. |
HOFFMAN R, BARLETTA G, VON BARDELEBEN S, et al. Analysis of left ventricular volumes and function:a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography[J]. J Am Soc Echocardiogr, 2014, 27(3):292-301.
|
3. |
MILLER C A, JORDAN P, BORG A, et al. Quantification of left ventricular indices from SSFP cine imaging:Impact of real-world variability in analysis methodology and utility of geometric modeling[J]. J Magn Reson Imaging, 2013, 37(5):1213-1222.
|
4. |
EVERITT M D, SLEEPER L A, LU M, et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy:results from the pediatric cardiomyopathy registry[J]. J Am Coll Cardiol, 2014, 63(14):1405-1413.
|
5. |
HERSHBERGER R E, HEDGES D J, MORALES A. Dilated cardiomyopathy:the complexity of a diverse genetic architecture[J]. Nat Rev Cardiol, 2013, 10(9):531-547.
|
6. |
MARON B J, TOWBIN J A, THIENE G, et al. Contemporary definitions and classification of the cardiomyopathies-An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention[J]. Circulation, 2006, 113(14):1807-1816.
|
7. |
HINSON J T, CHOPRA A, NAFISSI N, et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy[J]. Science, 2015, 349(6251):982-986.
|
8. |
ELLIOTT P, ANDERSSON B, ARBUSTINI E, et al. Classification of the cardiomyopathies:a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J, 2008, 29(2):270-276.
|
9. |
GIESBRANDT K J, BOLAN C W, SHAPIRO B P, et al. Diffuse diseases of the myocardium:MRI-Pathologic review of nondilated cardiomyopathies[J]. American Journal of Roentgenology, 2013, 200(3):W266-W273.
|
10. |
KIM J, KOCHAV J D, GUREVICH S, et al. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging[J]. Int J Cardiovasc Imaging, 2014, 30(8):1559-1567.
|
11. |
DONEKAL S, VENKATESH B A, LIU Y C, et al. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort:the Multi-Ethnic Study of Atherosclerosis(Mesa)study[J]. Circ Cardiovasc Imaging, 2014, 7(2):292-302.
|
12. |
DHARMAKUMAR R, SHARIF B, YANG H J. Basic principles of cardiovascular MRI[M]. Switzerland:Springer, 2015:25-40.
|
13. |
赵世华, 蒋世良, 陆敏杰.心血管病磁共振诊断学[M].北京:人民军医出版社, 2011:19-40.
|
14. |
RAJIAH P, BOLEN M. Cardiovascular MR imaging at 3 T:opportunities, challenges, and solutions[J].Radiographics, 2014, 34(6):1612-1635.
|
15. |
AMBALE-VENKATESH B, LIMA J A. Cardiac MRI:a central prognostic tool in myocardial fibrosis[J]. Nat Rev Cardiol, 2015, 12(1):18-29.
|
16. |
SYHA R, KETELSEN D, KAEMPF M, et al. In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla[J]. Eur Radiol, 2013, 23(2):588-595.
|
17. |
FERREIRA V M, PIECHNIK S K, ROBSON M D, et al. Myocardial tissue characterization by magnetic resonance imaging novel applications of T1 and T2 mapping[J]. J Thorac Imaging, 2014, 29(3):147-154.
|
18. |
SALERNO M, KRAMER C M. Advances in parametric mapping with CMR imaging[J]. JACC Cardiovasc Imaging, 2013, 6(7):806-822.
|
19. |
FOELL D, JUNG B A, GERMANN E, et al. Segmental myocardial velocities in dilated cardiomyopathy with and without left bundle branch block[J]. Journal of Magnetic Resonance Imaging, 2013, 37(1):119-126.
|
20. |
MCCROHON A, MOON J C, PRASAD S K, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance[J]. Circulation, 2003, 108(1):54-59.
|
21. |
MOON J C, MESSROGHLI D R, KELLMAN P, et al. Myocardial T1 mapping and extracellular volume quantification:a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement[J]. J Cardiovasc Magn Reson, 2013, 15:92.
|
22. |
DASS S, SUTTIE J J, PIECHNIK S K, et al. Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy[J]. Circ Cardiovasc Imaging, 2012, 5(6):726-733.
|
23. |
MORDI I, CARRICK D, BEZERRA H. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(7):797-803.
|
24. |
PUNTMANN V O, VOIGT T, CHEN Zhong, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy[J]. JACC Cardiovasc Imaging, 2013, 6(4):475-484.
|
25. |
NISHII T, KONO A K, SHIGERU M, et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy[J]. Int J Cardiovasc Imaging, 2014, 30(1):65-72.
|
26. |
CARPENTER J P, GRASSO A E, PORTER J B, et al. On myocardial siderosis and left ventricular dysfunction in hemochromatosis[J]. J Cardiovasc Magn Reson, 2013, 15:24.
|